Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-24 @ 7:02 PM
NCT ID: NCT06476457
Eligibility Criteria: Inclusion Criteria: * criteria 1. 18 years of age or older 2. ability to complete the study in English 3. agreed to be contacted for follow-up studies when consenting to the parent study 4. not currently enrolled in another form of psychotherapy 5. if currently prescribed medications, participants must be on a stable dosage of psychotropic medications (i.e., prescribed on stable dose for 1 month or more) 6. have a score of 33 or higher on the PCL-5 lifetime score in the parent study Exclusion Criteria: <!-- --> 1. less than 18 years of age 2. unable to complete the study in English 3. did not agree to be contacted for follow-up studies when consenting to the parent study 4. diagnosed with a psychotic disorder, unmedicated bipolar disorder, or severe substance-use disorder 5. experiencing ongoing long-term trauma as it is a contraindication for trauma focused treatment 6. experiencing acute levels of alcohol or is under the influence of an illegal substance, demonstrated by inpatient medical care for alcohol or substance abuse 7. participant is not competent to consent to the study as measured by the UBACC in the parent study 8. During parent study assessment (IRB23-0211), the participant receives a PCL score less than 33 9. Participant is receiving inpatient psychiatric care at the time of the study or experiencing involuntary detention
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT06476457
Study Brief:
Protocol Section: NCT06476457